期刊文献+

p16基因甲基化与急性淋巴细胞白血病的关系 被引量:1

Relationship between methylation of p16 gene and acute lymphoblastic leukemia
下载PDF
导出
摘要 目的 :探讨 p16基因甲基化在急性淋巴细胞白血病 (AL L)发生机制中的作用。方法 :采用限制性内切酶酶切结合多聚酶链反应方法检测 82例 AL L 患者白血病细胞 p16基因部分启动子和外显子 1Cp G岛甲基化的情况。结果 :31例 AL L 患者存在 p16基因的甲基化 ,1例 p16基因纯合缺失 ;p16存在甲基化与纯合缺失的患者初次化疗完全缓解率和平均生存时间低于 p16基因正常表达者。结论 :p16基因甲基化在 AL L 发生机制中有一定的作用 ,可作为评估 AL L 预后的一个指标。 Objective To investigate the effects of methylation p16 on pathogenesis of actue lymphoblastic leukemia.Methods The restriction endonuclease enzyme digestion combined with PCR was used to detect p16 gene and methylation in 82 patients with acute lymphoblastic leukemia. Results One homozygous deletion was found in these cases and methylation of p16 gene was found in 38.3% patients (31/81) . Patients without methylation of p16 gene had a higher complete remission rate of first chemotherapy and a longer survival time than those with methylation of p16 gene. Conclusion Methylation of p16 gene probably plays a role in the pathogenesis of acute lymphoblastic leukemia and may have a prognostic value.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2005年第1期124-126,共3页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅资助项目 (2 0 0 10 5 35 )
关键词 白血病 淋巴细胞 急性/病因学 基因 p16 甲基化 预后 leukemia,lymphocytic,acute/etiology genes,p16 methylation prognosis
  • 相关文献

参考文献8

  • 1邱吉庆,谭岩,赵刚,郭云宝,王长坤.人脑胶质瘤组织P^(16INK4)蛋白的表达及其基因突变SSCP分析[J].吉林大学学报(医学版),2003,29(3):273-276. 被引量:6
  • 2Guo SX, Taki T, Ohnishi H, et al. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia[J].Leu Res, 2000, 24 (1): 39-46.
  • 3Baur AS, Shaw P, Burri N, et al. Frequent methylation silencing of p15INK4b (MTS2) and p16INKa (MTS1) in B-cell and T-cell lymphomas [J]. Blood, 1999, 94 (5): 1773-1781.
  • 4Reed AL, Califano J, Cairas P, et al. High frequency of p16 (CDKN2/MTS1/INK4A) inactivation in head and neck squamous cell carcinoma[J]. Cancer Res, 1996,56: 3630-3633.
  • 5Nosaka K, Maeda M, Tamiya S, et al. Increasing mehylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia [J]. Cancer Res, 2000, 60: 1003-1010.
  • 6Gonzalez-Zulueta M, Bender CM ,Yang AS, et al. Methylation of the 5, CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with silencing [J]. Cancer Res, 1995, 55: 4531-4535.
  • 7Lee JH, Park SJ, Abraham SC, et al. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas [J]. Oncogene, 2004, 23 (26): 4646-4654.
  • 8Suzuki M, Sunaga N, Shames DS, et al. RNA interferencemediated knockdown of DNA methyltransferase leads to promoter demethylation and gene re-expression in human lung and breast cancer cells [J]. Cancer Res, 2004, 64 (9): 3137-3143.

二级参考文献7

  • 1Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types[J]. Science, 1994, 264 (5157): 436-440.
  • 2Okamoto A, Demetrick DJ, Spillare EA, et al. Mutations and altered expression of pl61NK4 in human cancer [J]. Proc Natl Acad Sci USA, 1994, 91 (23): 11045-11049.
  • 3Costello JF. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA [J]. Cancer Res, 1997, 57 (7): 1250-1254.
  • 4Peter B. Current concepts in neuro-oncology: the cell cycle-A Review [J]. Neurosurgery. 1997, 40 (5): 1000-1015.
  • 5Barker FG. p16 deletion and mutation analysis in human braintumors [J]. Neurooncol, 1997, 31 (1-2): 17-23.
  • 6Lukas J, Aagaard L, Strauss M, et al. Oncogenic aberrations of pl61NK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control [J]. Cancer Res, 1995, 55 (21): 4818-4823.
  • 7Hegi ME, Zur-hausen A. Ruedi D, et al. Hemizygous or homoaygous deletion of chromosomal region containing the pl6INK4 is associated with amplification of the EGF receptorgene in glioblastomas [J]. Int J Cancer, 1997.73 (1): 57-63.

共引文献5

同被引文献8

  • 1高素君,李薇,杨芳,王冠军.恶性血液病Flt_3基因内部串联重复突变分析[J].吉林大学学报(医学版),2004,30(4):591-592. 被引量:1
  • 2Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer [J]. Nature, 1998, 396:699-703.
  • 3Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necroslsfactor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis [ J ]. J Biol Chem, 1999, 274 (20) 113733-13736.
  • 4Bai C, Connlly B, Metzker ML, et al. Overexpression of M68/DeR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a fourgene cluster [J]. Proe Natl Aead Sei USA, 2000, 97 (3): 1230-1235.
  • 5Friesen C, Kiess Y. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells [J]. Cell Death Differ, 2004, 11 (Suppl 1):S73-85.
  • 6Lee JJ, Chung IJ, Park MR, et al. Increased anglo genesis and Fas-ligand expression are independent processes in acute myeloid leukemia [ J]. Leukemia Res, 2001, 25 (12):1067-1073.
  • 7Wu Y, Han B, Sheng H, et al. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients [J]. Int J Cancer, 2003, 105 (5): 724-732.
  • 8Takahama Y, Yamada Y, Emoto K, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas [J]. Gastric Cancer, 2002, 5 (2):61-68.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部